New York State Teachers Retirement System lowered its holdings in The Clorox Company (NYSE:CLX - Free Report) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 97,980 shares of the company's stock after selling 4,250 shares during the period. New York State Teachers Retirement System owned about 0.08% of Clorox worth $15,913,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Asset Planning Inc acquired a new position in Clorox in the fourth quarter worth approximately $32,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Clorox in the fourth quarter worth approximately $374,000. Retirement Guys Formula LLC grew its position in Clorox by 7.7% in the fourth quarter. Retirement Guys Formula LLC now owns 5,450 shares of the company's stock worth $885,000 after buying an additional 389 shares during the last quarter. Kentucky Trust Co acquired a new position in Clorox in the fourth quarter worth approximately $428,000. Finally, Viewpoint Capital Management LLC grew its position in Clorox by 15.3% in the fourth quarter. Viewpoint Capital Management LLC now owns 9,642 shares of the company's stock worth $1,566,000 after buying an additional 1,280 shares during the last quarter. Institutional investors own 78.53% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on CLX shares. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Finally, JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $158.21.
Get Our Latest Stock Report on Clorox
Clorox Stock Performance
CLX traded up $1.84 during trading on Thursday, hitting $152.93. The stock had a trading volume of 1,382,160 shares, compared to its average volume of 1,322,812. The firm has a market cap of $18.84 billion, a PE ratio of 41.78, a P/E/G ratio of 2.54 and a beta of 0.42. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a 50 day simple moving average of $158.11 and a 200-day simple moving average of $159.68.
Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm posted $2.16 EPS. Analysts expect that The Clorox Company will post 7.15 EPS for the current year.
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.